Date: 2014-11-17
Type of information: Nomination
Compound: member of the board of directors
Company: Merrimack Pharmaceuticals (USA - MA)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On November 17, 2014, Merrimack Pharmaceuticals announced the election of Vivian S. Lee to its Board of Directors. Lee currently serves as the Senior Vice President for Health Sciences at the University of Utah, Dean of the University's School of Medicine, and CEO of University of Utah Health Care, overseeing 15,000 employees. Prior to her position at the University of Utah, Lee served as Vice Dean for Science, Senior Vice President and Chief Scientific Officer of New York University Medical Center. She has also served as Chair of the Medical Imaging National Institute of Health (NIH) study section and is a Fellow and past President of the International Society of Magnetic Resonance in Medicine. Recently, Lee was appointed to the NIH Council of Councils. Lee is a graduate of Harvard-Radcliffe College and was awarded a Rhodes Scholarship to Oxford University, where she earned her doctorate degree in medical engineering in 1989. She earned her M.D. with honors at Harvard Medical School in 1992 and completed an M.B.A. at NYU\'s Stern School of Business in 2006. Lee's accomplishments have won her numerous awards and honors, including the Press Ganey Innovation Award and the Chang-Lin Tien Education Leadership Award.
Financial terms:
Latest news:
Is general: Yes
